MG

Minal Gaurishanker Pandya

Active Director Director DIN 10486214
DIN 10486214 First appointment Jan 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Minal Gaurishanker Pandya

Data last updated:

Minal Gaurishanker Pandya is a Director at Ajivan Healthtech Private Limited (since 2024).

DIN 10486214
Primary Designation Director
First Appointment 31 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ajivan Healthtech Private Limited U62099MH2024PTC418264
Director31 Jan 20242024Active

Board colleagues of Minal Gaurishanker Pandya

Directorship timeline

Open interactive timeline →
Ajivan Healthtech Private Limited
Premium access

Shareholding and investment profile for Minal Gaurishanker Pandya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Minal Gaurishanker Pandya

Minal Gaurishanker Pandya currently holds 1 directorship: Ajivan Healthtech Private Limited (Director, since 31 Jan 2024).

Minal Gaurishanker Pandya was first appointed on 31 Jan 2024 as Director at Ajivan Healthtech Private Limited.

The current boards of Minal Gaurishanker Pandya's companies include Rameshkumar Dungaraji Purohit (Ajivan Healthtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available